|
- 2019
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's diseaseDOI: 10.1002/acn3.754 Abstract: Microglia play a pivotal role in the initiation and progression of Alzheimer's disease (AD). We here tested the therapeutic hypothesis that the Ca2+‐activated potassium channel KCa3.1 constitutes a potential target for treating AD by reducing neuroinflammation
|